兔抗NAPSA多克隆抗体

Background:

The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.

Applications:

ELISA, WB, IHC

Name of antibody:

NAPSA

Immunogen:

Fusion protein of human NAPSA

Full name:

napsin A aspartic peptidase

Synonyms：

KAP; Kdap; NAP1; NAPA; SNAPA

SwissProt:

O96009

ELISA Recommended dilution:

1000-5000

IHC positive control:

Human liver cancer and Human gastric cancer

IHC Recommend dilution:

50-200

WB Predicted band size:

45 kDa

WB Positive control:

mouse kidney tissue

WB Recommended dilution:

500-2000